Cargando…

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia

Familial hypercholesterolemia (FH) is a common autosomal codominant genetic disorder, which causes elevated levels of low-density lipoprotein cholesterol (LDL-C) and increased risk of premature atherosclerotic cardiovascular disease (ASCVD). Even among individuals with monogenic FH, there is substan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trinder, Mark, Paquette, Martine, Cermakova, Lubomira, Ban, Matthew R., Hegele, Robert A., Baass, Alexis, Brunham, Liam R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889287/ https://www.ncbi.nlm.nih.gov/pubmed/33079599 http://dx.doi.org/10.1161/CIRCGEN.120.002919

Ejemplares similares

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019)

Patient Perspectives Regarding Genetic Testing for Familial Hypercholesterolemia
por: Marchand, Miles, et al.
Publicado: (2021)

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia
por: Ryzhaya, Natalia, et al.
Publicado: (2021)

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Polygenic determinants in extremes of high-density lipoprotein cholesterol
por: Dron, Jacqueline S., et al.
Publicado: (2017)

Genetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and “Missing” Heritability
por: Martín-Campos, Jesús Maria
Publicado: (2021)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia
por: Béland-Bonenfant, Sarah, et al.
Publicado: (2020)

Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
por: Wang, Anthony, et al.
Publicado: (2016)

The Polygenic and Monogenic Basis of Paediatric Fractures
por: Ghatan, S., et al.
Publicado: (2021)

Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
por: Olmastroni, Elena, et al.
Publicado: (2022)

The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada
por: Zhao, Pei Jun, et al.
Publicado: (2022)

Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia
por: Ohta, Akio, et al.
Publicado: (2017)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background
por: Bolli, Alessandro, et al.
Publicado: (2021)

From monogenic to polygenic obesity: recent advances
por: Hinney, Anke, et al.
Publicado: (2010)

The Polygenic and Monogenic Basis of Blood Traits and Diseases
por: Vuckovic, Dragana, et al.
Publicado: (2020)

SUN-557 Hypertriglyceridemia-Induced Pancreatitis: Experience from a Quaternary Care Center
por: Béland-Bonenfant, Sarah, et al.
Publicado: (2020)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Monogenic and polygenic inheritance become instruments for clonal selection
por: Loh, Po-Ru, et al.
Publicado: (2020)

Polygenic risk affects the penetrance of monogenic kidney disease
por: Khan, Atlas, et al.
Publicado: (2023)

Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
por: Schwarz, Andrea, et al.
Publicado: (2022)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Contemporary Polygenic Scores of Low-Density Lipoprotein Cholesterol and Coronary Artery Disease Predict Coronary Atherosclerosis in Adolescents and Young Adults
por: Guarischi-Sousa, Rodrigo, et al.
Publicado: (2023)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
por: Campuzano, Oscar, et al.
Publicado: (2020)

A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin
por: Leal, Luis G., et al.
Publicado: (2020)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Exploring the Efficacy of Alirocumab and Evolocumab in Reducing Low-Density Lipoprotein (LDL) Cholesterol Levels in Patients With Familial Hypercholesterolemia: A Systematic Review
por: Luthra, Gaurav, et al.
Publicado: (2022)

The Role of High-Density Lipoprotein Cholesterol in 2022
por: Sirtori, Cesare R., et al.
Publicado: (2022)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland
por: Björnsson, Eythór, et al.
Publicado: (2021)

Variation and impact of polygenic hematologic traits in monogenic sickle cell disease
por: Pincez, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pultec8mckeso9v6mjc3bshkui